Advertisement
Screener

Denali Therapeutics Inc. (DNLI) Patents: Active

Denali Therapeutics Inc. Active Patents

57 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-10-08: Application 19352786; Invention ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF; Applicant Denali Therapeutics Inc.; Status Patented Case.
  • 2025-08-19: Application 19304112; Invention ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF; Applicant DENALI THERAPEUTICS INC.; Status Patented Case.
  • 2025-03-17: Application 19081211; Invention FUSION PROTEINS COMPRISING ACID ALPHA-GLUCOSIDASE ENZYMES AND METHODS THEREOF; Applicant DENALI THERAPEUTICS INC.; Status Patented Case.
  • 2024-04-23: Application 18643692; Invention METHODS OF ENGINEERING TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES; Applicant Denali Therapeutics Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-10-0819352786ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2026-08-1112703761US20260109781A1
Abira BANDYOPADHYAY
Allisa Jayne CLEMENS
Do Jin KIM
Michelle E. PIZZO
Lu SHAN
Richard THÉOLIS Jr.
Raymond Ka Hang TONG
United States
United States
United States
United States
United States
United States
United States
ALSOMAIRY, SARAH ABDOALATIF
2025-08-1919304112ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOFDENALI THERAPEUTICS INC.Patented Case2026-05-2612636363US20250387477A1
Annie ARGUELLO
Tina GIESE
Gunasekaran KANNAN
Mihalis S. KARIOLIS
Cathal S. MAHON
Junhua WANG
United States
United States
United States
United States
United States
United States
MOSELEY II, NELSON B
2025-03-1719081211FUSION PROTEINS COMPRISING ACID ALPHA-GLUCOSIDASE ENZYMES AND METHODS THEREOFDENALI THERAPEUTICS INC.Patented Case2025-08-0512378540US20250250555A1
Mihalis S. KARIOLIS
Melina LENSER
Cathal S. MAHON
Hanh Giai NGO
Yashas RAJENDRA
Shrishti TYAGI
Tianao YUAN
United States
United States
United States
United States
United States
United States
United States
SAIDHA, TEKCHAND
2024-04-2318643692METHODS OF ENGINEERING TRANSFERRIN RECEPTOR BINDING POLYPEPTIDESDenali Therapeutics Inc.Patented Case2024-12-1012162948US20240271327A1
Xiaocheng Chen
Mark S. Dennis
Mihalis Kariolis
Adam P. Silverman
Ankita Srivastava
Ryan J. Watts
Robert C. Wells
Joy Yu Zuchero
United States
United States
United States
United States
United States
United States
United States
United States
BOESEN, CHRISTIAN C
2023-10-2618384080PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDSDENALI THERAPEUTICS INC.Patented Case2025-12-1612497387US20240158371A1
Mr. Travis REMARCHUK
Mr. Anantha SUDHAKAR
United States
United States
MCDOWELL, BRIAN E
2023-08-1018232435Compounds, Compositions and MethodsDenali Therapeutics Inc.Patented Case2025-07-1512358928US20240150376A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Colin Phillip Leslie
Joseph P. Lyssikatos
Alfonso Pozzan
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
Italy
United States
Italy
United States
United States
KIFLE, BRUCK
2023-06-1618268144SOLID FORMS OF A COMPOUNDDenali Therapeutics Inc.Patented Case2026-06-2312662458US20240059662A1
Christopher R.H. Hale
Yingqing Ran
Anantha Sudhakar
United States
United States
United States
JACKSON, SHAWQUIA
2023-01-1918099082COMPOUNDS, COMPOSITIONS, AND METHODSDENALI THERAPEUTICS INC.Patented Case2023-12-0511834439US20230227436A1
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2023-01-1118095621CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDEDenali Therapeutics Inc.Patented Case2024-06-0411999750US20230271978A1
Anantha Sudhakar
United States
COLEMAN, BRENDA LIBBY
2022-08-1517888406METHODS OF ENGINEERING TRANSFERRIN RECEPTOR BINDING POLYPEPTIDESDenali Therapeutics Inc.Patented Case2024-02-2711912778US20230235072A1
Xiaocheng Chen
Mark S. Dennis
Mihalis Kariolis
Adam P. Silverman
Ankita Srivastava
Ryan J. Watts
Robert C. Wells
Joy Yu Zuchero
United States
United States
United States
United States
United States
United States
United States
United States
BOESEN, CHRISTIAN C
2022-06-3017855543FUSION PROTEINS COMPRISING SULFOGLUCOSAMINE SULFOHYDROLASE ENZYMES AND METHODS THEREOFDENALI THERAPEUTICS INC.Patented Case2024-01-3011884944US20230062800A1
Tina GIESE
Gunasekaran KANNAN
Mihalis S. KARIOLIS
Cathal S. MAHON
United States
United States
United States
United States
DAHLE, CHUN WU
2022-03-2317702718COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2024-04-1611958840US20230114472A1
Robert A. Craig II
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian M. Fox
Maksim Osipov
Arun Thottumkara
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2022-03-1717697771PROGRANULIN VARIANTSDenali Therapeutics Inc.Patented Case2023-05-0911643446US20220213155A1
Gerald Maxwell Cherf
Gunasekaran Kannan
Katrina W. Lexa
Ray L.Y. Low
Rachel Prorok
Ankita Srivastava
United States
United States
United States
United States
United States
United States
EMCH, GREGORY S
2021-11-1917531039Modulators of eukaryotic initiation factor 2B, compositions and methodsDenali Therapeutics Inc.Patented Case2023-12-2611851440US20220411433A1
Robert A. Craig II
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian M. Fox
Christopher R.H. Hale
Katrina W. Lexa
Maksim Osipov
Travis Remarchuk
Zachary K. Sweeney
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2021-10-2617511193Kinase Inhibitors and Uses ThereofDenali Therapeutics Inc.Patented Case2024-10-2912129263US20220041620A1
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cinzia Maria Francini
Christopher R.H. Hale
Cheng Hu
Colin Philip Leslie
Maksim Osipov
Elena Serra
Zachary K. Sweeney
Arun Thottumkara
United States
United States
United States
United States
Italy
United States
United States
Italy
United States
Italy
United States
United States
COLEMAN, BRENDA LIBBY
2021-10-0817602480LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THEREOFDENALI THERAPEUTICS INC.Patented Case2025-07-1512358896US20220220094A1
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Zachary K. Sweeney
United States
United States
United States
United States
ISMAIL, REHANA
2021-10-0517494336Compounds, Compositions and MethodsDenali Therapeutics Inc.Patented Case2023-12-2611851433US20220024938A1
Giorgio Bonanomi
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cinzia Maria Francini
Cheng Hu
Colin Philip Leslie
Maksim Osipov
Anantha Sudhakar
Zachary K. Sweeney
Javier De Vicente Fidalgo
Italy
United States
United States
United States
Italy
United States
Italy
United States
United States
United States
United States
KIFLE, BRUCK
2021-09-3017600527FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASEDENALI THERAPEUTICS INC.Patented Case2026-06-3012667606US20220184186A1
Dana ANDERSEN
Adam CATHERMAN
Tina GIESE
Gunasekaran KANNAN
Mihalis S. KARIOLIS
Cathal S. MAHON
Ankit PATEL
United States
United States
United States
United States
United States
United States
United States
ALSOMAIRY, SARAH ABDOALATIF
2021-08-1617402986ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2025-03-0412240902US20220119522A1
Mark S. Dennis
Sherie Duncan
Kathleen Lisaingo
Kathryn M. Monroe
Joshua I. Park
Rachel Prorok
Ju Shi
Ankita Srivastava
Bettina Van Lengerich
Riley Walsh
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
MACFARLANE, STACEY NEE
2021-08-1317401833COMPOUNDS, COMPOSITIONS, AND METHODSDENALI THERAPEUTICS INC.Patented Case2023-02-2811591316US20220135546A1
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2021-08-1217430570COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2024-09-1712091392US20220177438A1
Robert A. Craig II
Javier de Vicente Fidalgo
Jianwen A. Feng
Maksim Osipov
Arun Thottumkara
United States
United States
United States
United States
United States
JACKSON, SHAWQUIA
2021-06-1717350581Compounds, Compositions and MethodsDenali Therapeutics Inc.Patented Case2024-12-3112180211US20210332058A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cheng Hu
Maksim Osipov
Zachary K. Sweeney
Javier de Vicente Fidalgo
Arun Thottumkara
United States
United States
United States
United States
United States
United States
United States
United States
NOTTINGHAM, KYLE GREGORY
2021-06-0717340513SUBSTITUTED PYRIMIDINES AS LRKK2 INHIBITORSDENALI THERAPEUTICS INC.Patented Case2023-12-1211840529US20210300914A1
Anthony A. ESTRADA
Jianwen A. FENG
Joseph P. LYSSIKATOS
Zachary K. SWEENEY
Javier DE VICENTE FIDALGO
United States
United States
United States
United States
United States
WILLIS, DOUGLAS M
2021-05-2817334587COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2022-04-1911306077US20210292311A1
Robert A. Craig II
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian M. Fox
Maksim Osipov
Arun Thottumkara
United States
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY
2021-01-1517151006ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2021-09-2111124567US20210214438A1
Mark S. Dennis
Zhenyu Gu
Mihalis S. Kariolis
Cathal S. Mahon
Kathryn M. Monroe
Joshua I. Park
Rachel Prorok
Adam P. Silverman
Bettina Van Lengerich
United States
United States
United States
United States
United States
United States
United States
United States
United States
OUSPENSKI, ILIA I
2020-11-2717105870POLYMORPHS AND SOLID FORMS OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF PRODUCTIONDenali Therapeutics Inc.Patented Case2022-08-3011427571US20210087176A1
Travis Remarchuk
Anantha Sudhakar
United States
United States
HABTE, KAHSAY
2020-11-2317102138FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMESDenali Therapeutics Inc.Patented Case2024-01-0911866742US20210198640A1
Anastasia Henry
Mihalis S. Kariolis
Cathal S. Mahon
Adam P. Silverman
Ankita Srivastava
Julie Ullman
United States
United States
United States
United States
United States
United States
PAK, MICHAEL D
2020-06-1816955717PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDSDENALI THERAPEUTICS INC.Patented Case2023-12-0511834438US20210009566A1
Travis Remarchuk
Anantha Sudhakar
United States
United States
MCDOWELL, BRIAN E
2020-05-0616867942ANTI-BACE1 ANTIBODIES AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2023-10-0311773185US20210070881A1
Mark S. Dennis
Jennifer A. Getz
Rinkan Shukla
Adam P. Silverman
Yin Zhang
Joy Yu Zuchero
United States
United States
United States
United States
United States
United States
WEN, SHARON X
2020-03-1316818745COMPOUNDS, COMPOSITIONS, AND METHODSDenali Therapeutics Inc.Patented Case2021-09-0711111235US20210002260A1
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2020-02-2816643168COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2024-11-1212139478US20200331900A1
Robert A. Craig II
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Katrina W. Lexa
Maksim Osipov
Zachary K. Sweeney
United States
United States
United States
United States
United States
United States
United States
YOO, SUN JAE
2020-02-0716637718MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2022-02-0111236100US20210147435A1
Robert A. Craig II
Javier de Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian M. Fox
Christopher R.H. Hale
Katrina W. Lexa
Maksim Osipov
Travis Remarchuk
Zachary K. Sweeney
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2019-12-1216621928PHOSPHO-RAB ANTIBODIES, ASSAYS AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2023-05-3011661461US20210147573A1
Jason C. Dugas
Anastasia Henry
Sarah Huntwork-Rodriguez
Michael T. Maloney
Nathan Moerke
Ella Negrou
Xiang Wang
United States
United States
United States
United States
United States
United States
United States
FONTAINHAS, AURORA M
2019-11-1416684340KINASE INHIBITORS AND USES THEREOFDenali Therapeutics Inc.Patented Case2021-12-2111203600US20200087319A1
Javier De Vicente Fidalgo
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cinzia Maria Francini
Christopher R.H. Hale
Cheng Hu
Colin Philip Leslie
Maksim Osipov
Elena Serra
Zachary K. Sweeney
Arun Thottumkara
United States
United States
United States
United States
Italy
United States
United States
Italy
United States
Italy
United States
United States
COLEMAN, BRENDA LIBBY
2019-11-1416683970Compounds, Compositions and MethodsDenali Therapeutics Inc.Patented Case2021-11-1611174262US20200079784A1
Giorgio Bonanomi
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cinzia Maria Francini
Cheng Hu
Colin Philip Leslie
Maksim Osipov
Anantha Sudhakar
Zachary K. Sweeney
Javier De Vicente Fidalgo
Italy
United States
United States
United States
Italy
United States
Italy
United States
United States
United States
United States
KIFLE, BRUCK
2019-09-1716573726ENGINEERED POLYPEPTIDESDenali Therapeutics Inc.Patented Case2023-08-2211732023US20200262890A1
Xiaocheng Chen
Mihalis Kariolis
Robert C. Wells
United States
United States
United States
ALLEN, MARIANNE P
2019-08-1616543367ANTI-TAU ANTIBODIES AND METHODS OF USE THEREOFDenali Therapeutics Inc.Patented Case2022-06-2811370832US20200216522A1
Xiaocheng Chen
Mark S. Dennis
Lesley Ann Kane
Do Jin Kim
Joseph W. Lewcock
Suresh Poda
Rishi Rakhit
Rinkan Shukla
Adam P. Silverman
United States
United States
United States
United States
United States
United States
United States
United States
United States
BALLARD, KIMBERLY
2019-08-1616543332ENGINEERED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDESDenali Therapeutics Inc.Patented Case2023-10-2411795232US20200223935A1
Xiaocheng Chen
Mark S. Dennis
Mihalis Kariolis
Adam P. Silverman
Ankita Srivastava
Ryan J. Watts
Robert C. Wells
Joy Yu Zuchero
United States
United States
United States
United States
United States
United States
United States
United States
WEIDNER, ADAM M
2019-06-2016447713POLYMORPHS AND SOLID FORMS OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF PRODUCTIONDenali Therapeutics Inc.Patented Case2020-12-0110851088US20190315723A1
Travis Remarchuk
Anantha Sudhakar
United States
United States
HABTE, KAHSAY
2019-06-0716434533Compounds, Compositions and MethodsDenali Therapeutics Inc.Patented Case2021-07-2711072618US20190300537A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Cheng Hu
Maksim Osipov
Zachary K. Sweeney
Javier de Vicente Fidalgo
Arun Thottumkara
United States
United States
United States
United States
United States
United States
United States
United States
SACKEY, EBENEZER O
2019-04-2616345637ANTI-APOE ANTIBODIESDenali Therapeutics Inc.
Washington University
Patented Case2021-09-2111124562US20190270794A1
David Holtzman
Hong Jiang
Fan Liao
Thu Nga Bien-Ly
Mark S. Dennis
Jing Guo
Adam P. Silverman
Ryan J. Watts
Yin Zhang
United States
United States
United States
United States
United States
United States
United States
United States
United States
EMCH, GREGORY S
2019-03-1516355339FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMESDenali Therapeutics Inc.Patented Case2020-12-2210870837US20190249155A1
Anastasia Henry
Mihalis Kariolis
Cathal Mahon
Adam P. Silverman
Ankita Srivastava
United States
United States
United States
United States
United States
PAK, MICHAEL D
2019-01-0415780620ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK1)Denali Therapeutics Inc.Patented Case2020-07-1410709692US20180353480A1
Giorgio Bonanomi
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Colin Philip Leslie
Joseph P. Lyssikatos
Carmela Napolitano
Alfonso Pozzan
Anantha Sudhakar
Zachary K. Sweeney
Federica Tonelli
Javier de Vicente Fidalgo
Italy
United States
United States
United States
Italy
United States
Italy
Italy
United States
United States
Italy
United States
ROZOF, TIMOTHY R
2018-11-2016197037POLYMORPHS AND SOLID FORMS OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF PRODUCTIONDenali Therapeutics Inc.Patented Case2019-08-0610370361US20190194170A1
Travis Remarchuk
Anantha Sudhakar
United States
United States
HABTE, KAHSAY
2018-10-1916165324TRANSFERRIN RECEPTOR TRANSGENIC MODELSDenali Therapeutics Inc.Patented Case2023-03-2811612150US20190274291A1
Mark S. Dennis
Adam P. Silverman
Joy Yu Zuchero
United States
United States
United States
NOBLE, MARCIA STEPHENS
2018-09-1316130817COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2020-03-3110604535US20190112318A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Colin Philip Leslie
Joseph P. Lyssikatos
Alfonso Pozzan
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
Italy
United States
Italy
United States
United States
KIFLE, BRUCK
2018-09-0716083438SUBSTITUTED PYRIMIDINES AS LRKK2 INHIBITORSDenali Therapeutics Inc.Patented Case2021-06-0811028080US20190084975A1
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
United States
United States
WILLIS, DOUGLAS M
2018-05-1715777205COMPOUND, COMPOSITIONS, AND METHODSDenali Therapeutics Inc.Patented Case2022-01-0411214565US20180327391A1
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
United States
United States
KIFLE, BRUCK
2018-03-2315934744ENGINEERED POLYPEPTIDESDenali Therapeutics Inc.Patented Case2019-10-2910457717US20180237496A1
Xiaocheng Chen
Mihalis Kariolis
Robert C. Wells
United States
United States
United States
KADER, KHALID
2018-03-2115927920COMPOUNDS, COMPOSITIONS, AND METHODSDenali Therapeutics Inc.Patented Case2020-03-1710590114US20180208582A1
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2018-03-1615923928TRANSFERRIN RECEPTOR TRANSGENIC MODELSDenali Therapeutics Inc.Patented Case2018-12-0410143187US20180235195A1
Mark S. Dennis
Adam P. Silverman
Joy Yu Zuchero
United States
United States
United States
NOBLE, MARCIA STEPHENS
2017-10-2515793882COMPOUNDS, COMPOSITIONS, AND METHODSDenali Therapeutics Inc.Patented Case2018-04-039932325US20180051009A1
Anthony A. Estrada
Jianwen A. Feng
Joseph P. Lyssikatos
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
United States
United States
SHAMEEM, GOLAM M
2017-09-2915721470COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2018-11-2010131676US20180099981A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Colin Philip Leslie
Joseph P. Lyssikatos
Alfonso Pozzan
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
Italy
United States
Italy
United States
United States
KIFLE, BRUCK
2017-09-2915721419COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2018-02-209896458US20180022759A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Zachary K. Sweeney
United States
United States
United States
United States
KIFLE, BRUCK
2017-02-0315424216COMPOUNDS, COMPOSITIONS AND METHODSDenali Therapeutics Inc.Patented Case2017-11-149815850US20170226127A1
Anthony A. Estrada
Jianwen A. Feng
Brian Fox
Colin Philip Leslie
Joseph P. Lyssikatos
Alfonso Pozzan
Zachary K. Sweeney
Javier de Vicente Fidalgo
United States
United States
United States
Italy
United States
Italy
United States
United States
KIFLE, BRUCK
2016-07-1515210927FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOFDenali Therapeutics, Inc.Patented Case2017-09-269771378US20170044182A1
Duane A. Burnett
Matthew Gregory Bursavich
Andrew J. McRiner
United States
United States
United States
BARKER, MICHAEL P
2016-06-1015178626OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOFDenali Therapeutics, Inc.Patented Case2017-10-319802927US20170066753A1
Raksha Acharya
Duane A. Burnett
Matthew Gregory Bursavich
Andrew Simon Cook
Bryce Alden Harrison
Andrew J. McRiner
United States
United States
United States
United States
United States
United States
HABTE, KAHSAY

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43